Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial
Open Access
- 1 February 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 393 (10170), 416-422
- https://doi.org/10.1016/s0140-6736(18)32989-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical benefit using sperm hyaluronic acid binding technique in ICSI cycles: a systematic review and meta-analysisReproductive BioMedicine Online, 2015
- Trends in Use of and Reproductive Outcomes Associated With Intracytoplasmic Sperm InjectionJAMA, 2015
- Advanced sperm selection techniques for assisted reproductionEmergencias, 2014
- Is sperm hyaluronic acid binding ability predictive for clinical success of intracytoplasmic sperm injection: PICSI vs. ICSI?Systems Biology in Reproductive Medicine, 2014
- A prospective randomized study to evaluate the effect of hyaluronic acid sperm selection on the intracytoplasmic sperm injection outcome of patients with unexplained infertility having normal semen parametersJournal of Assisted Reproduction and Genetics, 2013
- Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes—multicenter, double-blinded and randomized controlled trialHuman Reproduction, 2012
- Comparison of two ready-to-use systems designed for sperm–hyaluronic acid binding selection before intracytoplasmic sperm injection: PICSI vs. Sperm Slow: a prospective, randomized trialFertility and Sterility, 2012
- Who Invented the Delta Method?The American Statistician, 2012
- “Physiologic ICSI”: Hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo qualityFertility and Sterility, 2010
- Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyteThe Lancet, 1992